ESMO 2017 | Why should physicians and patients be educated about novel drugs?

Eric Jonasch, MD, from the The University of Texas MD Anderson Cancer Center, Houston, TX, discusses education doctors and patients at the European Society for Medical Oncology (ESMO) 2017 in Madrid, Spain. Education is continuously needed, at all levels, from oncologists to nurses, as well as patients, to ensure that novel drugs coming onto the market are properly understood. This will have a direct impact in the care and survival rates of patients.